Affimed Initiates Patient Recruitment for a Phase 1/2a Trial of Innate Cell Engager AFM24 in ...

Retrieved on: 2021-12-08 11:31:26

Tags for this article:

Click the tags to see associated articles and topics

Affimed Initiates Patient Recruitment for a Phase 1/2a Trial of Innate Cell Engager AFM24 in .... View article details on hiswai:

Excerpt

... Recruitment for a Phase 1/2a Trial of Innate Cell Engager AFM24 in Combination with Roche's Anti-PD-L1 Checkpoint Inhibitor Atezolizumab.

Article found on: www.globenewswire.com